Results

Total Results: 5,803 records

Showing results for "stimulants".

101. Section 5: Evidence, Attachment 1: AAP Guideline Evidence (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-1.pdf
     January 01, 2009 - results of the Multimodal Therapy of ADHD (MTA) study have identified a more persistent effect of stimulants … An uncommon additional significant adverse effect of stimulants is the occurrence of hallucinations

102. Enabling Electronic Prescribing and Enhanced Management of Controlled Medications - 2011 | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/enabling-electronic-prescribing-and-enhanced-management-controlled-medications/annual-summary/2011
     January 01, 2011 - of electronic prescribing (e-prescribing) to cover federally-controlled substances (e.g., narcotics, stimulants

103. Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/studies/index.html?page=275
     January 01, 2024 - Brown JP College students' perceived benefit-to-risk tradeoffs for nonmedical use of prescription stimulants … the variation in college students' perceived risks and benefits for nonmedical use of prescription stimulants … College students' perceived benefit-to-risk tradeoffs for nonmedical use of prescription stimulants:

104. Statistical Brief #473: Behavioral Medication Utilization in Children and Teenagers Ages 5-18 in the U.S. Civilian Noninstitutionalized Population, 2012 (pdf file)
     meps.ahrq.gov/data_files/publications/st473/stat473.pdf
     June 01, 2015 - therapeutic class code of psychotherapeutic agents (242) or a Cerner Multum therapeutic subclass code of CNS stimulants … therapeutic class code of psychotherapeutic agents (242) or a Cerner Multum therapeutic subclass code of CNS stimulants

105. Cancer-Anemia-Update Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia-update_executive.pdf
     April 01, 2013 - for initiating treatment compare regarding their effect on the benefits and harms of erythropoietic stimulants … optimal duration of therapy compare regarding their effect on the benefits and harms of erythropoietic stimulants

106. Psychosocial and Pharmacologic Interventions for Disruptive Behavior Disorders in Children and Adolescents: Current State of the Evidence (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/disruptive-behavior-disorder_clinician.pdf
     August 01, 2016 - range of psychotropic medications—including anticonvulsants, antipsychotics, mood stabilizers, and stimulants—have … improved in the intervention groups versus a control group over the short term (1–6 months). ��� Stimulants

107. Psychosocial and Pharmacologic Interventions for Disruptive Behavior Disorders in Children and Adolescents: Current State of the Evidence | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/disruptive-behavior-disorder/clinician
     August 31, 2016 - range of psychotropic medications--including anticonvulsants, antipsychotics, mood stabilizers, and stimulants … [evidence medium] Stimulants** (methylphenidate, amphetamine) Disruptive behaviors 2 (2 RCTs)

108. STATISTICAL BRIEF #473: Behavioral Medication Utilization in Children and Teenagers Ages 5-18 in the U.S. Civilian Noninstitutionalized Population, 2012
     meps.ahrq.gov/data_files/publications/st473/stat473.shtml
     June 01, 2015 - therapeutic class code of psychotherapeutic agents (242) or a Cerner Multum therapeutic subclass code of CNS stimulants … therapeutic class code of psychotherapeutic agents (242) or a Cerner Multum therapeutic subclass code of CNS stimulants

109. Psychosocial and Pharmacologic Interventions for Disruptive Behavior in Children and Adolescents (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/disruptive-behavior.pdf
     August 18, 2022 - interventions16- 18 (considered first-line treatment) and/or pharmacotherapy (e.g., antipsychotics, stimulants … pharmacologic interventions including alpha-agonists, anticonvulsants, beta-blockers, central nervous system stimulants … antipsychotics - beta-adrenergic blocking agents (i.e., beta- blockers) - central nervous system stimulants

110. Measures: Safe and Judicious Antipsychotic Use in Children and Adolescents (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/chipra_1415-p011-1-ef_0.pdf
     March 01, 2015 - Developments in pediatric psychopharmacology: focus on stimulants, antidepressants, and antipsychotics

111. ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of ADHD in Children and Adolescents (pdf file)
     www.cahps.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-5-attachment-5.pdf
     February 02, 2012 - Most studies that compared behavior therapy to stimulants found a much stronger ef­ fect on ADHD core … symptoms from stimulants than from behavior ther­ apy. … with less frequent monitoring and had less optimal re­ sults.65 Because stimulants might pro­ duce … Because stimulant medication effects are seen immediately, trials of different doses of stimulants … Illicit use of psycho- stimulants among college students: a pre­ liminary study.

112. Chipra-89-Adhd-Behavior-Section-5-Attach-5 (pdf file)
     www.cahps.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-5.pdf
     February 02, 2012 - An un- common additional significant ad- verse effect of stimulants is the occur- rence of hallucinations … Most studies that compared behavior therapy to stimulants found a much stronger ef- fect on ADHD core … symptoms from stimulants than from behavior ther- apy. … Because stimulant medication effects are seen immediately, trials of different doses of stimulants can … Illicit use of psycho- stimulants among college students: a pre- liminary study.

113. Chipra-89-Adhd-Behavior-Section-5-Attach-5 (pdf file)
     www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-5.pdf
     February 02, 2012 - An un- common additional significant ad- verse effect of stimulants is the occur- rence of hallucinations … Most studies that compared behavior therapy to stimulants found a much stronger ef- fect on ADHD core … symptoms from stimulants than from behavior ther- apy. … Because stimulant medication effects are seen immediately, trials of different doses of stimulants can … Illicit use of psycho- stimulants among college students: a pre- liminary study.

114. ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of ADHD in Children and Adolescents (pdf file)
     www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-5-attachment-5.pdf
     February 02, 2012 - Most studies that compared behavior therapy to stimulants found a much stronger ef­ fect on ADHD core … symptoms from stimulants than from behavior ther­ apy. … with less frequent monitoring and had less optimal re­ sults.65 Because stimulants might pro­ duce … Because stimulant medication effects are seen immediately, trials of different doses of stimulants … Illicit use of psycho- stimulants among college students: a pre­ liminary study.

115. Chipra-89-Adhd-Behavior-Section-5-Attach-5 (pdf file)
     www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-5.pdf
     February 02, 2012 - An un- common additional significant ad- verse effect of stimulants is the occur- rence of hallucinations … Most studies that compared behavior therapy to stimulants found a much stronger ef- fect on ADHD core … symptoms from stimulants than from behavior ther- apy. … Because stimulant medication effects are seen immediately, trials of different doses of stimulants can … Illicit use of psycho- stimulants among college students: a pre- liminary study.

116. Chipra-89-Adhd-Behavior-Section-5-Attach-5 (pdf file)
     www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-5.pdf
     February 02, 2012 - An un- common additional significant ad- verse effect of stimulants is the occur- rence of hallucinations … Most studies that compared behavior therapy to stimulants found a much stronger ef- fect on ADHD core … symptoms from stimulants than from behavior ther- apy. … Because stimulant medication effects are seen immediately, trials of different doses of stimulants can … Illicit use of psycho- stimulants among college students: a pre- liminary study.

117. ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of ADHD in Children and Adolescents (pdf file)
     www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-5-attachment-5.pdf
     February 02, 2012 - Most studies that compared behavior therapy to stimulants found a much stronger ef­ fect on ADHD core … symptoms from stimulants than from behavior ther­ apy. … with less frequent monitoring and had less optimal re­ sults.65 Because stimulants might pro­ duce … Because stimulant medication effects are seen immediately, trials of different doses of stimulants … Illicit use of psycho- stimulants among college students: a pre­ liminary study.

118. ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of ADHD in Children and Adolescents (pdf file)
     www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-5-attachment-5.pdf
     February 02, 2012 - Most studies that compared behavior therapy to stimulants found a much stronger ef­ fect on ADHD core … symptoms from stimulants than from behavior ther­ apy. … with less frequent monitoring and had less optimal re­ sults.65 Because stimulants might pro­ duce … Because stimulant medication effects are seen immediately, trials of different doses of stimulants … Illicit use of psycho- stimulants among college students: a pre­ liminary study.

119. ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of ADHD in Children and Adolescents (pdf file)
     www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-5-attachment-5.pdf
     February 02, 2012 - Most studies that compared behavior therapy to stimulants found a much stronger ef­ fect on ADHD core … symptoms from stimulants than from behavior ther­ apy. … with less frequent monitoring and had less optimal re­ sults.65 Because stimulants might pro­ duce … Because stimulant medication effects are seen immediately, trials of different doses of stimulants … Illicit use of psycho- stimulants among college students: a pre­ liminary study.

120. Chipra-89-Adhd-Behavior-Section-5-Attach-5 (pdf file)
     www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-5.pdf
     February 02, 2012 - An un- common additional significant ad- verse effect of stimulants is the occur- rence of hallucinations … Most studies that compared behavior therapy to stimulants found a much stronger ef- fect on ADHD core … symptoms from stimulants than from behavior ther- apy. … Because stimulant medication effects are seen immediately, trials of different doses of stimulants can … Illicit use of psycho- stimulants among college students: a pre- liminary study.